Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

217P - Survival outcomes in patients with lung cancer and major vessel invasion undergoing curative intent radiotherapy

Date

28 Mar 2025

Session

Poster Display session

Presenters

Gerard Gurumurthy

Citation

Journal of Thoracic Oncology (2025) 20 (3): S123-S150. 10.1016/S1556-0864(25)00632-X

Authors

G.J. Gurumurthy1, S.C. Bowen Jones2, A. Lodhi2, A. Umar3, J. Mercer2, C. Barker2, K. Banfill2, N. Bayman2, C. Chan2, J. Coote2, M. Harris2, J. King2, L. Pemberton2, H. Sheikh2, D. Woolf2, A. Salem4, C. Faivre-Finn2

Author affiliations

  • 1 The University of Manchester, Manchester/GB
  • 2 The Christie NHS Foundation Trust, Manchester/GB
  • 3 Manchester University NHS Foundation Trust, Manchester/GB
  • 4 The Hashemite University, Zarqa/JO

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 217P

Background

Lung cancer with vascular invasion (VI) into major vessels is associated with poor prognosis and risk of broncho-pulmonary hemorrhage. Evidence regarding safety and efficacy of curative intent radiotherapy is limited. We assessed outcomes and toxicity in patients with VI treated with curative intent (chemo)radiotherapy using established VI classifications.

Methods

We retrospectively analysed 45 patients with stage I–III lung cancer and documented VI via the electronic patient record between 06/19-06/23. 3 radiologists graded VI using the Han (2014) and Ma (2023) classifications. Overall survival (OS) and prognostic accuracy of VI classifications were analysed using Kaplan Meier and Cox hazards models.

Results

The table summarises patients and tumour characteristics. Radiological review revealed 7 patients did not have VI under either classifications. Median follow-up was 17.8 months (95% CI=11.2–20.8). Median OS was 32.6 months (95% CI=16.4–not reached), 31.2 months (95% CI=11.2 – not reached) and 19.4 months (95% CI=10.8 – not reached) for the whole cohort, Grade 0 and Grade 1+ respectively. Neither classification significantly stratified survival (p=0.07). Hazard ratios of death per unit increase in VI grade were 1.40 (95% CI=0.93–2.12) for Ma and 1.27 (95% CI=1.02–1.58) for Han. No Grade 5 pulmonary hemorrhage occurred. 2 patients (4.4%) died within 3 months of radiotherapy due to disease progression.

Table 217P

Summary of demographics, treatment information and vessel involvement

Demographicsn=45
Median Age (IQR)72.0 (63.0–87.0)
Male24 (53.3%)
Female21 (46.7%)
TNM Staging
Stage 17 (15.6%)
Stage 25 (11.1%)
Stage 333 (73.3%)
Treatment
Radiotherapy alone27 (60.0%)
Sequential Chemoradiotherapy9 (20.0%)
Concurrent Chemoradiotherapy9 (20.0%)
Grading of Invasion
Han (2014)
G07 (15.6%)
G118 (40.0%)
G25 (11.1%)
G36 (13.3%)
G43 (6.7%)
G56 (13.3%)
Ma (2023)
G07 (15.6%)
G123 (51.1%)
G29 (20.0%)
G36 (13.3%)

Conclusions

Curative intent (chemo)radiotherapy in patients with VI was not associated with treatment-related deaths, even in high VI grades. The established VI classifications lacked prognostic value in this small cohort. Refinement of classification systems are needed to improve decision making for patients and clinicians.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.